Kinex Pharmaceuticals LLC — Form D

Kinex Pharmaceuticals LLC of BUFFALO, NY, a company, filed a Form D exempt-offering notice with the SEC on 2017-05-03. The offering totals $20.0M, of which $20.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (39)

Showing 25 of 39 people.

NameRoleLocation
Antony LeungDirectorBuffalo, NY
Song-Yi ZhangDirectorBuffalo, NY
Rudolph KwanExecutive OfficerBuffalo, NY
Nick RiehleExecutive OfficerBuffalo, NY
Michael MurphyDirectorNew York, NY
Charles LannonDirectorWilliamsville, NY
James HusseyExecutive OfficerAustin, TX
Jeffrey YordonExecutive OfficerSchaumburg, IL
Allen BarnettDirectorAvondale, PA
Allen BarnettExecutive OfficerAvondale, PA
Johnson LauDirectorXi'an, F4
Johnson LauExecutive OfficerXi'an, F4
Randoll SzeExecutive OfficerBuffalo, NY
Rudolf KwanExecutive OfficerBuffalo, NY
Simon PedderExecutive OfficerCharlotte, NC
Jinn WuDirectorPrinceton Junction, NJ
John VierlingDirectorBuffalo, NY
Benson TsangDirectorBuffalo, NY
John KohDirectorBuffalo, NY
Jordan KanferDirectorBuffalo, NY
Manson FokDirectorBuffalo, NY
Stephanie DavisDirectorBuffalo, NY
William ZuoExecutive OfficerBuffalo, NY
Kim CampbellDirectorBuffalo, NY
SongYi ZhangDirectorBuffalo, NY

Other filings by this issuer (12)

FiledFormOfferingSold
2019-12-11D$60.4M$60.4M
2019-05-15D$100.0M$100.0M
2018-07-17D$50.0M$50.0M
2016-10-07D$50.0M$37.9M
2015-06-16D$10.0M$10.0M
2015-06-16D/A$74.4M
2015-05-20D$62.8M$48.1M
2013-12-23D$40.0M$300K
2012-08-06D$40.0M$5.0M
2011-04-25D$5.0M$4.7M
2010-02-03D/A$6.0M$4.1M
2010-01-07D$6.0M$3.8M

More